Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP, PL, and PPP for Atrophied Multifidus Muscles in Low Back Pain
NCT03618979Terminated
- Sponsor
- Regenexx
- Start
- May 2019
- Primary completion
- Jun 2022
- Modality
- Adipose-derived MSCs, Bone Marrow MSCs
- Countries
- 1
01
Overview
Randomised trial of platelet-rich plasma in low back pain (LBP) and muscle atrophy (3 arms), sponsored by Regenexx. Primary endpoint: Post-treatment MRI (Changes to Multifidus Atrophy) at 6 months. Started May 2019; status: terminated.
02
Drugs
platelet-rich plasma
03
Conditions
low back pain (LBP)muscle atrophy
Beyond the preview
Go deeper on NCT03618979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03618979.